Hepatic Lactate Dehydrogenase A : An RNA Interference Target for the Treatment of All Known Types of Primary Hyperoxaluria
-
Ariceta Iraola, Gema (Hospital Universitari Vall d'Hebron)
;
Barrios, Kelly (Dicerna Pharmaceuticals, Inc., Lexington) ;
Brown, Bob D. (Dicerna Pharmaceuticals, Inc., Lexington) ;
Hoppe, Bernd (German Hyperoxaluria Center Cologne/Bonn) ;
Rosskamp, Ralf (Dicerna Pharmaceuticals, Inc., Lexington) ;
Langman, Craig B. (Ann and Robert H. Lurie Children's Hospital of Chicago) ;
Universitat Autònoma de Barcelona
visitante ::
identificación
Subscribirse to this discussion. You will then receive all new comments by email.
